Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Unknown Primary × Everolimus × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Carcinoma, Renal Cell 10 Neuroendocrine Tumors 8 Neoplasm Metastasis 8 Recurrence 5 Endometrial Neoplasms 4 Tuberous Sclerosis 3 Neoplasms 3 Glioma 3 Glioblastoma 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Meningioma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Kidney Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Diffuse Intrinsic Pontine Glioma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Thymus Neoplasms 1 Seizures 1

Interventions

pembrolizumab 2 atezolizumab 2 zenocutuzumab 1 sintilimab 1 pertuzumab 1 pemigatinib 1 olaparib 1 ivosidenib 1 ipatasertib 1 entrectinib 1 cobimetinib 1 alectinib 1 Whole Genome Sequencing 1 Vemurafenib 1 Transurethral Resection of Prostate 1 Specimen Handling 1 Sequence Analysis, RNA 1 Radiosurgery 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 HhAntag691 1 Genetic Testing 1 Genetic Profile 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 FAPI-46 1 Erlotinib Hydrochloride 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡